The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 727 KB) and Technical Notes (PDF, 1.1 MB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 3.11

Age-Adjusted SEER Incidencea , by Year and Sex

By Adapted Classification Scheme for Tumors of Adolescents and Young Adultsb

All Races, Ages 35-39

Both Sexes

Site 1975-2018 2009-2018
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 113,030 135.7 0.7* 29,010 145.1 0.1
1. Leukemias 3,252 3.9 0.6 911 4.6 1.9*
2. Lymphomas 9,128 11.0 1.1* 2,005 10.0 -1.4*
3. CNS, intracranial, intraspinal 3,287 3.9 -0.2 749 3.7 -0.2
4. Osseous & chondromatous neoplasms 570 0.7 1.2* 156 0.8 1.2*
5. Soft tissue sarcomas 6,561 7.9 0.7 876 4.4 -1.4*
6. Germ cell and trophoblastic neoplasms 5,033 6.0 1.5* 1,329 6.6 0.4*
7. Melanoma and skin carcinomas 12,239 14.7 1.4* 3,140 15.7 0.3*
8. Carcinomas (excluding skin) 70,191 84.3 0.5* 18,869 94.4 0.4
9. Miscellaneous specified neoplasms, NOS 2,144 2.6 2.8* 828 4.1 2.5*
10. Unspecified malignant neoplasms 569 0.7 -0.5 114 0.6 -0.5

Males

Site 1975-2018 2009-2018
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 41,765 100.6 0.5* 9,742 97.7 0.2
1. Leukemias 1,877 4.5 0.4* 506 5.1 0.4*
2. Lymphomas 5,845 14.1 1.1* 1,161 11.6 -1.6*
3. CNS, intracranial, intraspinal 1,907 4.6 -0.3 426 4.3 -0.3
4. Osseous & chondromatous neoplasms 319 0.8 0.5 83 0.8 0.5
5. Soft tissue sarcomas 5,050 12.2 1.7 528 5.3 -2.0*
6. Germ cell and trophoblastic neoplasms 4,778 11.5 1.6* 1,259 12.6 0.4*
7. Melanoma and skin carcinomas 5,238 12.6 0.6 1,227 12.3 -0.4*
8. Carcinomas (excluding skin) 15,599 37.6 0.3* 4,159 41.7 1.1*
9. Miscellaneous specified neoplasms, NOS 902 2.2 2.4 335 3.4 1.5
10. Unspecified malignant neoplasms 220 0.5 -1.1 39 0.4 -1.1

Females

Site 1975-2018 2009-2018
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 71,265 170.6 0.7* 19,268 192.3 0.3
1. Leukemias 1,375 3.3 0.9 405 4.0 1.3*
2. Lymphomas 3,283 7.9 1.0* 844 8.4 -0.8
3. CNS, intracranial, intraspinal 1,380 3.3 -0.1 323 3.2 -0.1
4. Osseous & chondromatous neoplasms 251 0.6 - 73 0.7 -
5. Soft tissue sarcomas 1,511 3.6 -0.4 348 3.5 -0.4
6. Germ cell and trophoblastic neoplasms 255 0.6 0.1 70 0.7 0.1
7. Melanoma and skin carcinomas 7,001 16.8 1.7 1,913 19.1 0.5*
8. Carcinomas (excluding skin) 54,592 130.7 0.5* 14,710 146.8 0.4
9. Miscellaneous specified neoplasms, NOS 1,242 3.0 3.6* 493 4.9 3.6*
10. Unspecified malignant neoplasms 349 0.8 -0.2 75 0.7 -0.2

Footnotes:

Rates are per 100,000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

a Rates are from the SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta).

b Adapted from: RD Barr, EJ Holowaty, JM Birch. Classification Scheme for tumors diagnosed in adolescents and young adults. Cancer. 106:7; 1425-1430. (Restricted to malignant tumors and updated based on ICD-O-3 definitions).

c The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint over the time range of 1975-2018.

- Statistic could not be calculated. Count and rate based on less than 16 cases for the time interval. AAPC could not be calculated due to insufficient data.

* The AAPC is significantly different from zero (p<.05).

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.